AB.PA
AB Science SA
Price:  
1.22 
EUR
Volume:  
48,464.00
France | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

AB.PA EV/EBITDA

-195.4%
Upside

As of 2026-04-02, the EV/EBITDA ratio of AB Science SA (AB.PA) is -14.05. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. AB.PA's latest enterprise value is 94.75 mil EUR. AB.PA's TTM EBITDA according to its financial statements is -6.75 mil EUR. Dividing these 2 quantities gives us the above AB.PA EV/EBITDA ratio.

Note: valuation result may not be accurate due to the company's negative EBITDA.

Range Selected
Trailing P/E multiples 5.1x - 6.5x 6.5x
Forward P/E multiples 10.5x - 12.6x 12.1x
Fair Price (1.28) - (0.88) (1.16)
Upside -205.4% - -171.9% -195.4%
1.22 EUR
Stock Price
(1.16) EUR
Fair Price

AB.PA EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA
2026-03-26 -13.57
2026-03-25 -13.44
2026-03-24 -13.11
2026-03-23 -13.66
2026-03-20 -13.91
2026-03-19 -14.01
2026-03-18 -14.22
2026-03-17 -14.22
2026-03-16 -14.11
2026-03-13 -14.07
2026-03-12 -14.32
2026-03-11 -14.58
2026-03-10 -14.89
2026-03-09 -14.40
2026-03-06 -14.73
2026-03-05 -14.81
2026-03-04 -14.89
2026-03-03 -14.30
2026-03-02 -14.85
2026-02-27 -15.36
2026-02-26 -15.44
2026-02-25 -15.40
2026-02-24 -15.32
2026-02-23 -15.15
2026-02-20 -15.22
2026-02-19 -15.05
2026-02-18 -14.70
2026-02-17 -14.70
2026-02-16 -14.62
2026-02-13 -15.11
2026-02-12 -15.15
2026-02-11 -15.24
2026-02-10 -15.70
2026-02-09 -15.54
2026-02-06 -15.64
2026-02-05 -15.56
2026-02-04 -15.74
2026-02-03 -15.77
2026-02-02 -15.93
2026-01-30 -15.87
2026-01-29 -15.74
2026-01-28 -15.93
2026-01-27 -16.07
2026-01-26 -16.01
2026-01-23 -16.19
2026-01-22 -16.19
2026-01-21 -15.56
2026-01-20 -15.60
2026-01-19 -15.64
2026-01-16 -15.95